These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15779384)

  • 1. [Obesity and the metabolic syndrome].
    Masuzaki H; Nakao K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():264-8. PubMed ID: 15779384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperuricemia as a unique marker for metabolic syndrome].
    Nakajima H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():269-73. PubMed ID: 15779385
    [No Abstract]   [Full Text] [Related]  

  • 3. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems of metabolic syndrome diagnostics in children.
    Vitariusova E; Kostalova L; Pribilincova Z; Hlavata A; Kovacs L
    Endocr Regul; 2010 Jul; 44(3):115-20. PubMed ID: 20799854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
    Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
    Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and metabolic syndrome in obese and non-obese children.
    Moreno LA; Pineda I; Rodríguez G; Fleta J; Giner A; Juste MG; Sarría A; Bueno M
    Horm Metab Res; 2002 Jul; 34(7):394-9. PubMed ID: 12189588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance.
    Cohn GS; Kittleson MM; Blumenthal RS
    Am J Hypertens; 2005 Aug; 18(8):1099-103. PubMed ID: 16109324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
    Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
    J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: one step forward, two steps back.
    Kim SH; Reaven GM
    Diab Vasc Dis Res; 2004 Oct; 1(2):68-75. PubMed ID: 16304726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: diagnosis.
    Harv Mens Health Watch; 2006 Jun; 10(11):6-8. PubMed ID: 16775867
    [No Abstract]   [Full Text] [Related]  

  • 19. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The metabolic syndrome and insulin resistance].
    Kotani K; Kaku K
    Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.